- Home
- LSTA vs FTHM Comparison
LSTA vs FTHM Comparison
Compare LSTA & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- FTHM
- Stock Information
- Founded
- LSTA 1980
- FTHM 2010
- Country
- LSTA United States
- FTHM United States
- Employees
- LSTA N/A
- FTHM N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- FTHM Real Estate
- Sector
- LSTA Health Care
- FTHM Finance
- Exchange
- LSTA Nasdaq
- FTHM Nasdaq
- Market Cap
- LSTA 20.9M
- FTHM 33.6M
- IPO Year
- LSTA N/A
- FTHM 2020
- Fundamental
- Price
- LSTA $2.80
- FTHM $1.24
- Analyst Decision
- LSTA Strong Buy
- FTHM Buy
- Analyst Count
- LSTA 1
- FTHM 1
- Target Price
- LSTA $15.00
- FTHM $2.50
- AVG Volume (30 Days)
- LSTA 14.5K
- FTHM 79.7K
- Earning Date
- LSTA 08-11-2025
- FTHM 08-11-2025
- Dividend Yield
- LSTA N/A
- FTHM N/A
- EPS Growth
- LSTA N/A
- FTHM N/A
- EPS
- LSTA N/A
- FTHM N/A
- Revenue
- LSTA $1,000,000.00
- FTHM $357,816,000.00
- Revenue This Year
- LSTA N/A
- FTHM $32.40
- Revenue Next Year
- LSTA N/A
- FTHM $18.04
- P/E Ratio
- LSTA N/A
- FTHM N/A
- Revenue Growth
- LSTA N/A
- FTHM 5.80
- 52 Week Low
- LSTA $1.87
- FTHM $0.65
- 52 Week High
- LSTA $4.20
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- LSTA 59.64
- FTHM 58.94
- Support Level
- LSTA $2.36
- FTHM $1.24
- Resistance Level
- LSTA $2.69
- FTHM $1.36
- Average True Range (ATR)
- LSTA 0.22
- FTHM 0.08
- MACD
- LSTA 0.02
- FTHM -0.01
- Stochastic Oscillator
- LSTA 62.50
- FTHM 70.73
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.